What AI says about Karius

Karius applies clinical metagenomics and AI to detect microbes responsible for infections by sequencing microbial cell-free DNA circulating in the bloodstream. Its products include Karius Spectrum, a plasma metagenomic sequencing test that detects over 1,000 pathogens, and Karius Focus BAL, a bronchoalveolar lavage-based test that detects hundreds of lung-infection pathogens. The goal is rapid, comprehensive infectious-disease diagnostics to improve patient care, including immunocompromised individuals, with CLIA-certified and CAP-accredited laboratories.

AI named Karius in August 2026.